Group 1 - Ainanju (920770) announced that several shareholders plan to reduce their holdings, with a maximum reduction of 147.17 thousand shares (1.1309%) by Jiaxing Xinmeng Investment Co., Ltd. and 67.92 thousand shares (0.5219%) by Zhang Lianghua [2] - Huaguangyuanhai (920351) reported that its controlling shareholders intend to reduce their stakes, with a maximum reduction of 43.6875 thousand shares (0.5%) by Changsha Yuan San Enterprise Management Consulting Partnership and similar reductions by other related parties [3] - Xinganjiang (920367) disclosed that major shareholders have completed their share reduction plans, with Zhang Ming reducing 55.9803 thousand shares (0.79%) for a total of 12.23 million yuan [4] Group 2 - Jinbo Biological (920982) received approval from the China Securities Regulatory Commission for a stock issuance to specific investors, valid for 12 months [5] - Danna (920009) signed a significant construction contract worth approximately 126 million yuan with China Construction Sixth Engineering Bureau, scheduled to start on January 26, 2026 [6] - Parallel Technology (920493) plans to purchase GPU computing servers and other assets, with total contracts not exceeding 185.2 million yuan [7] Group 3 - Fujida (920640) announced that two IEC international standards it led have been approved for publication, filling a gap in international specifications for RF coaxial cable components [8][9] - Honghai Technology (920108) plans to invest approximately 95.4 million yuan in constructing a new factory in Thailand as part of its strategic development [10] - Yintu Network (920508) reported the purchase of financial products totaling 24 million yuan to enhance the efficiency of its idle funds [11] - Jiangtian Technology (920121) announced a cash management initiative using 50 million yuan of idle funds [12]
北交所重要公告汇总（2026年1月22日）